Bone density in Ehlers-Danlos syndrome.

Area of Science:

• Orthopedics
• Genetics
• Metabolic Bone Disease

Background:

• Ehlers-Danlos Syndrome (EDS) is a common inherited connective tissue disorder.
• Bone health is a concern in connective tissue disorders.
• Understanding bone mineral density (BMD) and metabolism in EDS is crucial.

Purpose of the Study:

• To assess bone mineral density (BMD) in Ehlers-Danlos Syndrome (EDS) patients.
• To evaluate biochemical markers of bone and connective tissue metabolism in EDS.
• To compare these measures between EDS patients and healthy controls.

Main Methods:

• Dual-energy X-ray absorptiometry (DXA) was used to measure BMD at the lumbar spine and femoral neck.
• Twenty-three subjects with Type III EDS and 23 matched controls participated.
• Health history questionnaires and biochemical markers were also analyzed.

Main Results:

• No significant differences in lumbar spine BMD or biochemical markers were observed between groups.
• EDS subjects showed significantly lower femoral neck BMD compared to controls.
• This difference in femoral neck BMD became non-significant after adjusting for height, weight, and physical activity.

Conclusions:

• Type III Ehlers-Danlos Syndrome does not appear to significantly alter bone metabolism or lumbar spine bone mineral density.
• The observed decrease in femoral neck bone mineral density in EDS is likely influenced by biomechanical factors rather than intrinsic bone metabolism changes.
• Further research may explore the long-term implications of these biomechanical factors on bone health in EDS.